Submicroscopic infections among children with adequate clinical and parasitological response (ACPR)

Acta Tropica

Volumn 134, Issue 1, 2014, Pages 29-32

  Mawili Mboumba, D P ^a   Bouyou Akotet, M K ^a   Kombila, M ^a  

^a UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

Author keywords

ACPR PCR; P. falciparum; Submicroscopic infections

Indexed keywords

ARTESUNATE PLUS MEFLOQUINE; PYRIMETHAMINE PLUS SULFADOXINE; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PROTOZOAL DNA; PYRIMETHAMINE; SULFADOXINE;

DISEASE TREATMENT; DNA; MALARIA; PARASITE; PARASITOLOGY; POLYMERASE CHAIN REACTION; PROTOZOAN;

ADEQUATE CLINICAL AND PARASITOLOGICAL RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL INDICATOR; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; DRUG EFFICACY; DRUG TREATMENT FAILURE; ETHNIC GROUP; FEMALE; GABONESE; HUMAN; MALARIA FALCIPARUM; MALE; MEDICAL PARAMETERS; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PATIENT ASSESSMENT; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; BLOOD; DRUG COMBINATION; EVALUATION STUDY; GABON; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MICROSCOPY; PARASITOLOGY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME;

GABON;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; BLOOD; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; DRUG COMBINATIONS; FEMALE; GABON; HUMANS; MALARIA, FALCIPARUM; MALE; MICROSCOPY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

EID: 84896113136     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2014.01.007     Document Type: Article

References (27)

1. Beshir K.B., Sutherland C.J., Sawa P., Drakeley C.J., Okell L., Mweresa C.K., Omar S.A., Shekalaghe S.A., Kaur H., Ndaro A., Chilongola J., Schallig H.D., Sauerwein R.W., Hallett R.L., Bousema T. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J. Infect. Dis. 2013, 208:2017-2024.
2. Bousema J.T., Schneider P., Gouagna L.C., Drakeley C.J., Tostmann A., Houben R., Githure J.I., Ord R., Sutherland C.J., Omar S.A., Robert R.W. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J. Infect. Dis. 2006, 193:1151-1159.
3. Bouyou-Akotet M.K., Ramharter M., Ngoungou E.B., Mabika Mamfoumbi M., Pemba Mihindou M., Missinou M.A., Kurth F., Bélard S., Agnandji S.T., Issifou S., Heidecker J.L., Trapp S., Kremsner P.G., Kombila M. Efficacy and safety of a new pediatric artesunate mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon. Wien. Klin. Wochenschr. 2010, 122:173-178.
4. Denis M.B., Tsuyuoka R., Poravuth Y., Narann T.S., Seila S., Lim C., Incardona S., Lim P., Sem R., Socheat D., Christophel E.M., Ringwald P. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop. Med. Int. Health 2006, 11:1360-1366.
5. Denis M.B., Tsuyuoka R., Lim P., Lindegardh N., Yi P., Top S.N., Socheat D., Fandeur T., Annerberg A., Christophel E.M., Ringwald P. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop. Med. Int. Health 2006, 11:1800-1807.
6. Huho B.J., Killeen G.F., Ferguson M.H., Tami A., Lengeler C., Charlwood J.D., Kihonda A., Kihonda J., Kachur S.P., Smith T.A., Abdulla S.M. Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission. Malar. J. 2012, 11:118-129.
7. Jarra W., Snounou G. Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses. Infect. Immun. 1998, 66:3783-3787.
8. Mawili-Mboumba D.P., Borrman S., Cavanagh D.R., McBride J.S., Matsiegui P.B., Missinou M.A., Kremsner P.G., Ntoumi F. Antibody response to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malaria. J. Infect. Dis. 2003, 187:1137-1141.
9. Mawili-Mboumba D.P., Bouyou Akotet M.K., Ngoungou E.B., Kombila M. Evaluation of rapid diagnostic tests for malaria case management in Gabon. Diagn. Microbiol. Infect. Dis. 2010, 66:162-166.
10. Mawili-Mboumba D.P., Bouyou-Akotet M.K., Kombila M. Parental administration of unprescribed antimalarial drugs to treat febrile children in Gabon. Sante 2011, 21:127-131.
11. Mawili-Mboumba D.P., Nikiéma R., Bouyou-Akotet M.K., Bahamontes-Rosa N., Traoré A., Kombila M. Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon. Malar. J. 2013, 12:375-380.
12. Mombo-Ngoma G., Oyakhirome S., Ord R., Gabor J.J., Greutélaers K.C., Profanter K., Greutélaers B., Kurth F., Lell B., Kun J.F., Issifou S., Roper C., Kremsner P.G., Grobusch M.P. High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Malar. J. 2011, 10:123. 10.1186/1475-2875-10-123.
13. Nsimba B., Guiyedi V., Mabika Mamfoumbi M., Mourou-Mbina J.R., Ngoungou E., Bouyou-Akotet M., Loembet R., Durand R., Le Bras J., Kombila M. Sulfadoxine-pyriméthamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide the national policy. Malar. J. 2008, 7:31-37.
14. Ntoumi F., Contamin H., Rogier C., Bonnefoy S., Trape J.F., Mercereau-Puijalon O. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am. J. Trop. Med. Hyg. 1995, 52:81-88.
15. Okell L.C., Bousema T., Griffin J.T., Ouédraogo A.L., Ghani A.C., Drakeley C.J. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat. Commun. 2012, 4:1237.
16. Oyedeji S.I., Awobode H.O., Monday G.C., Kendjo E., Kremsner P.G., Kun J.F. Comparison of PCR-based detection of Plasmodium falciparum infections based on single and multicopy genes. Malar. J. 2007, 6:112-117.
17. Programme national de lutte contre le paludisme (PNLP) Rapport de l'atelier national de consensus sur les perspectives thérapeutiques du paludisme 2003.
18. Ramharter M., Schuster K., Bouyou-Akotet M.K., Adegnika A.A., Schmits K., Mombo-Ngoma G., Agnandji S.T., Nemeth J., Afène S.N., Issifou S., Onnas I.N., Kombila M., Kremsner P.G. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am. J. Trop. Med. Hyg. 2007, 77:418-422.
19. Robert F., Ntoumi F., Angel G., Diatta B., Rogier C., Fandeur T., Sarthou J.L., Mercereau-Puijalon O. Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:704-711.
20. Shekalaghe S., Drakeley C., Gosling R., Ndaro A., van Meegeren M., Enevold A., Alifrangis M., Mosha F., Sauerwein R., Bousema T. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE 2007, 2:e1023.
21. Sowunmi A., Gbotosho G.O., Happi C., Okuboyejo T., Folarin O., Balogun S., Michael O. Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria. Am. J. Trop. Med. Hyg. 2009, 81:979-986.
22. Stepniewsa K., White N. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malar. J. 2006, 5:127.
23. Stepniewska K., Ashley E., Lee S.J., Anstey N., Barnes K.I., Binh T.Q., D'Alessandro U., Day N.P., de Vries P.J., Dorsey G., Guthmann J.P., Mayxay M., Newton P.N., Olliaro P., Osorio L., Price R.N., Rowland M., Smithuis F., Taylor W.R., Nosten F., White N.J. In vivo parasitological measures of artemisinin susceptibility. J. Infect. Dis. 2010, 201:570-579. 10.1086/650301.
24. Whegang S.Y., Tahar R., Foumane V.N., Soula G., Gwét H., Thalabard J.C., Basco L.K. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malar. J. 2010, 9:56-65.
25. White N.J. Qinghaosu (artemisinin): the price of success. Science 2008, 320:330-334.
26. Wongsrichanalai C., Meshnick S.R. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg. Infect. Dis. 2008, 14:716-719.
27. World Health Organization Genotyping to identify parasite populations - libdoc.who.int - World 2006, http://whqlibdoc.who.int/publications/2008/9789241596305_eng.pdf.